Related references
Note: Only part of the references are listed.Mutasynthesis of geldanamycin by the disruption of a gene producing starter unit: Generation of structural diversity at the benzoquinone ring
Woncheol Kim et al.
CHEMBIOCHEM (2007)
Biosynthesis of the heat-shock protein 90 inhibitor geldanamycin: New insight into the formation of the benzoquinone moiety
DH Lee et al.
CHEMBIOCHEM (2006)
Interaction of Hsp90 with ribosomal proteins protects from ubiquitination and proteasome-dependent degradation
TS Kim et al.
MOLECULAR BIOLOGY OF THE CELL (2006)
Heat shock protein 90 inhibitors. A text book example of medicinal chemistry?
YL Janin
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Preclinical toxicity of a geldanamycin analog, 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin (17-DMAG), in rats and dogs: potential clinical relevance
ER Glaze et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2005)
Structure-based design of 7-carbamate analogs of geldanamycin
G Rastelli et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2005)
In vivo antitumor efficacy of 17-DMAG (17-dimethylaminoethylamino-17-demethoxygeldanamycin hydrochloride), a water-soluble geldanamycin derivative
M Hollingshead et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2005)
Phase I and pharmacologic study of 17-(allylamino)-17-demethoxygeldanamycin in adult patients with solid tumors
JL Grem et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Phase I trial of 17-allylamino-17-demethoxygeldanamycin in patients with advanced cancer
MP Goetz et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Molecular chaperones and the stress of oncogenesis
DD Mosser et al.
ONCOGENE (2004)
Inactivation of the carbamoyltransferase gene refines post-polyketide synthase modification steps in the biosynthesis of the antitumor agent geldanamycin
YS Hong et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2004)
Engineered biosynthesis of geldanamycin analogs for Hsp90 inhibition
K Patel et al.
CHEMISTRY & BIOLOGY (2004)
Therapeutic and diagnostic implications of Hsp90 activation
A Kamal et al.
TRENDS IN MOLECULAR MEDICINE (2004)
Synthesis and biological activities of novel 17-aminogeldanamycin derivatives
ZQ Tian et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2004)
Crystal structure and molecular modeling of 17-DMAG in complex with human Hsp90
JM Jez et al.
CHEMISTRY & BIOLOGY (2003)
Development of a purine-scaffold novel class of Hsp90 binders that inhibit the proliferation of cancer cells and induce the degradation of Her2 tyrosine kinase
G Chiosis et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2002)
Total synthesis of (+)-geldanamycin and (-)-o-quinogeldanamycin with use of asymmetric anti- and syn-glycolate aldol reactions
MB Andrus et al.
ORGANIC LETTERS (2002)
Hsp90 inhibitors as novel cancer chemotherapeutic agents
L Neckers
TRENDS IN MOLECULAR MEDICINE (2002)
Improved synthesis and evaluation of 17-substituted aminoalkylgeldanamycin derivatives applicable to drug delivery systems
Y Kasuya et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2001)
Sensitivity of mature ErbB2 to geldanamycin is conferred by its kinase domain and is mediated by the chaperone protein Hsp90
WP Xu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Synthesis and evaluation of geldanamycin-testosterone hybrids
SD Kuduk et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2000)
Share Paper
